cervical cancer,semaphorin 4C (Sema4C),
Showing 1 - 25 of >10,000
Diagnosis Value of SEMA4C in Breast Cancer
Not yet recruiting
- Breast Neoplasm Female
- Breast cancer group
- Benign breast tumor group
- (no location specified)
Oct 18, 2022
SEMA4C as a Relapse Biomarker in Breast Cancer
Not yet recruiting
- Breast Cancer
- SEMA4C high value follow-up group
- SEMA4C low value follow-up group
- (no location specified)
Oct 6, 2021
Cervical Multifidus Muscle Area on Interlaminar Epidural Steroid
Not yet recruiting
- Cervical Radiculopathy
- Cervical multifidus muscle area measurement at 3 levels (C4-C5, C5-C6, C6-C7)
- (no location specified)
Jul 14, 2023
Uterine Cervical Tumors Trial in Toronto (Hyperpolarized 13C-Pyruvate, 18F-FDG)
Terminated
- Uterine Cervical Neoplasms
- Hyperpolarized 13C-Pyruvate
- 18F-FDG
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Sep 20, 2022
Healthy Trial in Porto (HVLA C3/C4 manipulation, Sham technique)
Not yet recruiting
- Healthy
- HVLA C3/C4 manipulation
- Sham technique
-
Porto, PortugalEscola Superior da Saúde do Porto
Mar 23, 2022
Lung Cancer Trial in Montréal (Cervical mediastinoscopy)
Recruiting
- Lung Cancer
- Cervical mediastinoscopy
-
Montréal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal
Feb 10, 2022
Malignant Solid Tumor Trial in Philadelphia (Biopsy, Biospecimen Collection, Echocardiography)
Active, not recruiting
- Malignant Solid Neoplasm
- Biopsy
- +5 more
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Nov 15, 2023
Survivorship, Breast Cancer, Cervical Cancer Trial in Cork (Survivorship Clinic Assessments, Survivorship Clinic Nurse Resource,
Recruiting
- Survivorship
- +3 more
- Survivorship Clinic Assessments
- +2 more
-
Cork, IrelandCork University Hospital
Jun 2, 2022
Spinal Cord Injury, Spinal Cord Injury at C5-C7 Level, SCI - Spinal Cord Injury Trial in Canada
Recruiting
- Spinal Cord Injury
- +7 more
-
Vancouver, British Columbia, Canada
- +3 more
Dec 1, 2022
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Follicular Lymphoma, Recurrent Indolent Adult Non-Hodgkin Lymphoma Trial in
Suspended
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +7 more
- Venetoclax
- +3 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 20, 2023
Anatomic Stage IV Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Copanlisib
- +2 more
-
Los Angeles, California
- +4 more
Jul 19, 2022
Chronic HIV Infection Trial in United States (426c.Mod.Core-C4b, Adjuvant 3M-052-AF+Alum)
Not yet recruiting
- Chronic HIV Infection
- 426c.Mod.Core-C4b
- Adjuvant 3M-052-AF+Alum
-
Birmingham, Alabama
- +6 more
Aug 17, 2023
Acute Myeloid Leukemia Trial in Nashville (Biopsy of Bone, Cytarabine, Daunorubicin)
Recruiting
- Acute Myeloid Leukemia
- Biospecimen Collection
- +5 more
-
Buffalo, New York
- +1 more
Jan 27, 2023
Advanced Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Duarte (Clostridium
Active, not recruiting
- Advanced Renal Cell Carcinoma
- +5 more
- Clostridium butyricum CBM 588 Probiotic Strain
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 12, 2022
HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer Trial in Canada (Endocrine therapy may include one of the following
Active, not recruiting
- HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer
- Endocrine therapy may include one of the following therapies: letrozole, anastrozole, exemestane, tamoxifen or fulvestrant
- Endocrine therapy in combination with targeted therapy may include: everolimus plus exemestane or CDK4/6 inhibitor plus endocrine therapy
-
Calgary, Alberta, Canada
- +24 more
Sep 12, 2022
HER2 Positive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer Trial in Palo Alto (Utomilumab, Trastuzumab,
Completed
- HER2 Positive Breast Carcinoma
- +6 more
- Utomilumab
- +2 more
-
Palo Alto, CaliforniaStanford University, School of Medicine
Sep 22, 2022
Burnout, Caregiver, Compassion Fatigue Trial in Halifax (Circuit-based Resistance Training, Circuit-based Resistance Training +
Not yet recruiting
- Burnout, Caregiver
- Compassion Fatigue
- Circuit-based Resistance Training
- +2 more
-
Halifax, Nova Scotia, CanadaPhysical Activity and Cancer (PAC) Lab
May 30, 2023
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +19 more
- pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 1, 2022
Locally Advanced Cervical Cancer Trial in Worldwide (Volrustomig, Placebo)
Recruiting
- Locally Advanced Cervical Cancer
- Volrustomig
- Placebo
-
Savannah, Georgia
- +85 more
Oct 6, 2023
Lung Cancer Trial in Toronto (Sentry System)
Recruiting
- Lung Cancer
- Sentry System
-
Toronto, Ontario, CanadaToronto General Hospital
Mar 27, 2023
Non-melanoma Skin Cancer, Carcinoma, Squamous Cell, Carcinoma, Basal Cell Trial in Canada (Nicotinamide, Placebo)
Not yet recruiting
- Non-melanoma Skin Cancer
- +3 more
- Nicotinamide
- Placebo
-
Calgary, Alberta, Canada
- +7 more
Jul 13, 2023
HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IIA Breast Cancer Trial in Duarte, Lancaster, South Pasadena
Active, not recruiting
- HER2-positive Breast Cancer
- +9 more
- pertuzumab
- +3 more
-
Duarte, California
- +2 more
Mar 17, 2022
Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone
Not yet recruiting
- Acute Myeloid Leukemia With KMT2A Rearrangement
- Acute Myeloid Leukemia With NPM1 Mutation
- Biospecimen Collection
- +7 more
- (no location specified)
Jun 1, 2023